Drug Profile
Research programme: Akt inhibitors - SRI International
Alternative Names: SR-13676Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator SRI International
- Class Indoles; Small molecules
- Mechanism of Action Proto oncogene protein c-akt inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer